心臓マッピングの世界市場レポート 2025年

心臓マッピング市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3％で32億9,000万米ドルに成長します。予測期間の成長は、心血管疾患の有病率の増加、高齢化人口の増加、認知度の向上とスクリーニングプログラム、ヘルスケアインフラの改善、健康問題の有病率の上昇に起因しています。予測期間の主な動向としては、人工知能（AI）との統合、リアルタイム3Dマッピングシステム、カテーテル技術の向上、クラウドベースのデータ解析、電気生理学ソフトウェアの強化などが挙げられます。

心臓マッピング市場は、不整脈、心臓発作、心不全などの合併症を引き起こし、心臓の構造や機能に影響を及ぼすさまざまな疾患を含む心臓疾患の有病率の増加により、成長する見込みです。座りがちなライフスタイル、食生活の乱れ、人口の高齢化などが、こうした疾患の発生率上昇の一因となっています。心臓マッピングは、心臓のリズムにおける電気的異常を正確に特定することにより、心臓疾患の診断と治療に重要な役割を果たしています。例えば、英国心臓財団（British Heart Foundation）は2024年1月に、英国では100万人以上が心不全に苦しんでおり、毎年約20万人が新たに診断され、約73万人がGP心不全登録に含まれていると報告しています。このことは、心臓疾患の蔓延がいかに心臓マッピング市場の成長を促しているかを裏付けています。

心臓マッピング市場の主要企業は、診断精度と治療効果を向上させるため、心臓マッピングプラットフォームなどの先進ソリューションの開発に注力しています。これらのプラットフォームは、心臓内の電気的活動を可視化・解析する高度な技術を採用しており、不整脈などの診断や治療に役立っています。例えば、米国のヘルスケア企業であるアボット・ラボラトリーズは、2022年1月にEnSite X EPシステムのFDA 510（k）認可を取得しました。このプラットフォームは、カテーテルの向きに関係なく、包括的な360度ビューを提供する詳細な3Dマップを生成することにより、医師が異常な心臓リズムの起源を突き止めるのを助ける。このシステムは、アボット独自のEnSiteオムニポーラ・テクノロジー（OT）とアドバイザーのHDグリッド・カテーテルを利用し、どのカテーテルの角度からでも正確なエレクトログラムを捉えることができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓マッピング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心臓マッピング市場：成長率分析
• 世界の心臓マッピング市場の実績：規模と成長, 2019-2024
• 世界の心臓マッピング市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓マッピング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓マッピング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓マッピング Systemsへのお問い合わせ
• 非接触型心臓マッピングシステム
• 世界の心臓マッピング市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心房細動
• 心房粗動
• 房室結節リエントリー性頻拍（AVNRT）
• その他の適応症
• 世界の心臓マッピング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断センター
• その他のエンドユーザー
• 世界の心臓マッピング市場、連絡先システムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 電極ベースマッピングシステム
• カテーテルベースのマッピングシステム
• 統合マッピングおよびアブレーションシステム
• 3Dマッピングシステム
• 世界の心臓マッピング市場非接触型システムのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非接触電圧マッピングシステム
• 心電図マッピングシステム
• 光学マッピングシステム
• 磁場マッピングシステム

第7章 地域別・国別分析

• 世界の心臓マッピング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓マッピング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓マッピング市場：競合情勢
• 心臓マッピング市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• Epmap-System
• APN Health LLC
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology Co. Ltd.
• MicroPort Scientific Corporation
• Biosense Webster Inc.
• BioSig Technologies Inc.
• CardioFocus Inc.
• Kardium Inc.
• Acutus Medical Inc.
• Navix Medical Ltd.
• EP Solutions SA
• CoreMap Inc.
• Catheter Precision Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓マッピング市場2029：新たな機会を提供する国
• 心臓マッピング市場2029：新たな機会を提供するセグメント
• 心臓マッピング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cardiac mapping involves creating a detailed representation of the heart's electrical activity to pinpoint abnormal rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This data is essential for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats.

The primary types of cardiac mapping systems are contact cardiac mapping and non-contact cardiac mapping. Contact cardiac mapping systems utilize electrodes in direct contact with heart tissue to precisely identify and map electrical activity. They are used for diagnosing and treating conditions such as atrial fibrillation, atrial flutter, and atrioventricular nodal reentrant tachycardia (AVNRT). These systems are employed by hospitals, clinics, diagnostic centers, and other healthcare facilities.

The cardiac mapping research report is one of a series of new reports from The Business Research Company that provides cardiac mapping market statistics, including the cardiac mapping industry's global market size, regional shares, competitors with a cardiac mapping market share, detailed cardiac mapping market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac mapping industry. This cardiac mapping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac mapping market size has grown strongly in recent years. It will grow from $2.3 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the introduction of catheter ablation, development of 3D mapping systems, improvements in imaging technologies, rise in the prevalence of cardiac arrhythmias, and growth in minimally invasive procedures.

The cardiac mapping market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing aging population, rising awareness and screening programs, improved healthcare infrastructure, and rising prevalence of health issues. Major trends in the forecast period include integration with artificial intelligence (AI), real-time 3D mapping systems, improved catheter technologies, cloud-based data analysis, and enhanced electrophysiology software.

The cardiac mapping market is poised for growth due to increasing prevalence of heart ailments, which encompass various conditions affecting the heart's structure and function, leading to complications such as arrhythmias, heart attacks, and heart failure. Sedentary lifestyles, poor dietary habits, and aging populations contribute to the rising incidence of these ailments. Cardiac mapping plays a crucial role in diagnosing and treating heart conditions by precisely identifying electrical abnormalities in the heart's rhythm. For example, the British Heart Foundation reported in January 2024 that over one million individuals in the UK suffer from heart failure, with approximately 200,000 new cases diagnosed annually and around 730,000 people included in GP heart failure registers. This underscores how the prevalence of heart ailments is fueling growth in the cardiac mapping market.

Leading companies in the cardiac mapping market are focusing on developing advanced solutions such as cardiac mapping platforms to improve diagnostic precision and treatment effectiveness. These platforms employ sophisticated technologies to visualize and analyze electrical activity within the heart, aiding in the diagnosis and treatment of cardiac arrhythmias and other conditions. For instance, Abbott Laboratories, a US-based healthcare company, received FDA 510(k) clearance in January 2022 for its EnSite X EP system. This platform helps physicians pinpoint origins of abnormal heart rhythms by generating detailed 3D maps that offer a comprehensive 360-degree view, regardless of catheter orientation. The system utilizes Abbott's proprietary EnSite omnipolar technology (OT) and advisor HD grid catheter to capture accurate electrograms from any catheter angle.

In August 2022, Medtronic Plc, a US-based medical technology firm, acquired Affera Inc. for $925 million. This acquisition expands Medtronic's cardiac ablation portfolio to include Affera's advanced cardiac mapping and navigation platform, alongside its diagnostic and therapeutic catheters. Affera Inc., based in the US, specializes in developing systems for cardiac mapping and ablation.

Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies, Boston Scientific Corporation, Epmap-System, APN Health LLC, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Biosense Webster Inc., BioSig Technologies Inc., CardioFocus Inc., Kardium Inc., Acutus Medical Inc., Navix Medical Ltd., EP Solutions SA, CoreMap Inc., Catheter Precision Inc.

North America was the largest region in the cardiac mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac mapping market consists of revenues earned by entities by providing services such as monitoring and follow-up, diagnostic mapping, and ablation guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac mapping market also includes sales of electrophysiology mapping systems, mapping software, navigation systems, and ablation catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Mapping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac mapping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac mapping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac mapping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Contact Cardiac Mapping Systems; Non-Contact Cardiac Mapping Systems
• 2) By Indications: Atrial Fibrillation; Atrial Flutter; Atrioventricular Nodal Reentrant Tachycardia (AVNRT); Other Indications
• 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems; Catheter-Based Mapping Systems; Integrated Mapping And Ablation Systems; 3D Mapping Systems
• 2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems; Electrocardiographic Mapping Systems; Optical Mapping Systems; Magnetic Field Mapping Systems
• Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; GE Healthcare Technologies
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Mapping Market Characteristics

3. Cardiac Mapping Market Trends And Strategies

4. Cardiac Mapping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Mapping Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Mapping PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Mapping Market Growth Rate Analysis
• 5.4. Global Cardiac Mapping Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Mapping Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Mapping Total Addressable Market (TAM)

6. Cardiac Mapping Market Segmentation

• 6.1. Global Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems
• 6.2. Global Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atrial Fibrillation
• Atrial Flutter
• Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
• Other Indications
• 6.3. Global Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Other End-User
• 6.4. Global Cardiac Mapping Market, Sub-Segmentation Of Contact Cardiac Mapping Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrode-Based Mapping Systems
• Catheter-Based Mapping Systems
• Integrated Mapping And Ablation Systems
• 3D Mapping Systems
• 6.5. Global Cardiac Mapping Market, Sub-Segmentation Of Non-Contact Cardiac Mapping Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Contact Voltage Mapping Systems
• Electrocardiographic Mapping Systems
• Optical Mapping Systems
• Magnetic Field Mapping Systems

7. Cardiac Mapping Market Regional And Country Analysis

• 7.1. Global Cardiac Mapping Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Mapping Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Mapping Market

• 8.1. Asia-Pacific Cardiac Mapping Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Mapping Market

• 9.1. China Cardiac Mapping Market Overview
• 9.2. China Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Mapping Market

• 10.1. India Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Mapping Market

• 11.1. Japan Cardiac Mapping Market Overview
• 11.2. Japan Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Mapping Market

• 12.1. Australia Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Mapping Market

• 13.1. Indonesia Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Mapping Market

• 14.1. South Korea Cardiac Mapping Market Overview
• 14.2. South Korea Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Mapping Market

• 15.1. Western Europe Cardiac Mapping Market Overview
• 15.2. Western Europe Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Mapping Market

• 16.1. UK Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Mapping Market

• 17.1. Germany Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Mapping Market

• 18.1. France Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Mapping Market

• 19.1. Italy Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Mapping Market

• 20.1. Spain Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Mapping Market

• 21.1. Eastern Europe Cardiac Mapping Market Overview
• 21.2. Eastern Europe Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Mapping Market

• 22.1. Russia Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Mapping Market

• 23.1. North America Cardiac Mapping Market Overview
• 23.2. North America Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Mapping Market

• 24.1. USA Cardiac Mapping Market Overview
• 24.2. USA Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Mapping Market

• 25.1. Canada Cardiac Mapping Market Overview
• 25.2. Canada Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Mapping Market

• 26.1. South America Cardiac Mapping Market Overview
• 26.2. South America Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Mapping Market

• 27.1. Brazil Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Mapping Market

• 28.1. Middle East Cardiac Mapping Market Overview
• 28.2. Middle East Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Mapping Market

• 29.1. Africa Cardiac Mapping Market Overview
• 29.2. Africa Cardiac Mapping Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Mapping Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Mapping Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Mapping Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Mapping Market Competitive Landscape
• 30.2. Cardiac Mapping Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Technologies Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Mapping Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Epmap-System
• 31.3. APN Health LLC
• 31.4. BIOTRONIK SE & Co. KG
• 31.5. Lepu Medical Technology Co. Ltd.
• 31.6. MicroPort Scientific Corporation
• 31.7. Biosense Webster Inc.
• 31.8. BioSig Technologies Inc.
• 31.9. CardioFocus Inc.
• 31.10. Kardium Inc.
• 31.11. Acutus Medical Inc.
• 31.12. Navix Medical Ltd.
• 31.13. EP Solutions SA
• 31.14. CoreMap Inc.
• 31.15. Catheter Precision Inc.

32. Global Cardiac Mapping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Mapping Market

34. Recent Developments In The Cardiac Mapping Market

35. Cardiac Mapping Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Mapping Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Mapping Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Mapping Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer